Robert M. Fielding

Robert M. Fielding joined Olatec’s Drug Development Team in September 2013 and became a member of the Scientific Advisory Board in November 2018, contributing leading expertise in the design and conduct of Olatec’s pharmacology programs. Mr. Fielding has over 30 years of experience in the pharmaceutical and biotech industries, including formulation evaluation, preclinical pharmacokinetics/toxicokinetics, pharmacology and clinical pharmacokinetic studies for more than 30 products now approved or in clinical trials. He has contributed over 90 articles, abstracts and reviews on the subjects of liposomal antibiotics, bronchodilators and antineoplastics, hemoglobin-based oxygen carriers, oligonucleotides, inhalation delivery, sustained release formulations and drug delivery systems. Prior to founding Biologistic Services in 1998, Mr.Fielding held positions at Liposome Technology, Somatogen, Nexagen and NeXstar Pharmaceuticals, Inc. He is a member of the American Association of Pharmaceutical Scientists, the American Society for Microbiology and the Society of Toxicology. Mr. Fielding received his BS in Chemistry and his MS in Organic Chemistry from University of California, Riverside, and studied Physiology at the University of California, San Francisco.